GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Gopro Inc. (GPRO) [hlAlert]

Rating:
Overweight
GPRO
down 29.37 %

Gopro Inc. (GPRO) rated Overweight with price target $40 by Barclays

Posted on: Thursday,  Oct 29, 2015  2:25 PM ET by Barclays

Barclays rated Overweight Gopro Inc. (NASDAQ: GPRO) on 10/29/2015. Previously Barclays rated Overweight Gopro Inc. (NASDAQ: GPRO) on 04/23/2012., when
the stock price was $67.62. Since then, Gopro Inc. has lost 29.37% as of 01/14/2016's recent price of $47.76.
If you would have followed the previous Barclays's recommendation on GPRO, you would have lost 29.37% of your investment in 1361 days.

Gen-Probe Inc. is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid testing (NAT) products used for the clinical diagnosis of human diseases and for screening donated human blood. Using its patented NAT technology, Gen-Probe has received FDA approvals for more than 40 products that detect a wide variety of infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, pneumonia and fungal infections.

Barclays
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/29/2015 2:25 PM Buy
None
25.69 40.00
as of 8/27/2015
1 Week down  -24.26 %
1 Month down  -15.85 %
3 Months down  -5.64 %
1 YTD down  -21.58 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/22/2015 1:25 PM Buy
None
60.91 71.00
10/7/2014 12:25 PM Buy
None
97.89 60.00
7/21/2014 12:00 AM Buy
None
41.58 45.00
4/23/2012 1:25 PM Buy
None
67.62 70.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy